Patients' Understanding and Attitudes Towards Infliximab and Etanercept Biosimilars: Result of a UK Web-Based Survey.
- Published in:
- BioDrugs, 2017, v. 31, n. 5, p. 439, doi. 10.1007/s40259-017-0238-1
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2017 AND VI 31 AND IP 5
Results: 8
1
2
SB2: An Infliximab Biosimilar.
- Published in:
- BioDrugs, 2017, v. 31, n. 5, p. 461, doi. 10.1007/s40259-017-0240-7
- By:
- Publication type:
- Article
3
Monoclonal Antibodies for Atopic Dermatitis: Progress and Potential.
- Published in:
- BioDrugs, 2017, v. 31, n. 5, p. 409, doi. 10.1007/s40259-017-0241-6
- By:
- Publication type:
- Article
4
Asthma Phenotypes and Endotypes: Implications for Personalised Therapy.
- Published in:
- BioDrugs, 2017, v. 31, n. 5, p. 393, doi. 10.1007/s40259-017-0242-5
- By:
- Publication type:
- Article
5
Advances in the Application and Impact of MicroRNAs as Therapies for Skin Disease.
- Published in:
- BioDrugs, 2017, v. 31, n. 5, p. 423, doi. 10.1007/s40259-017-0243-4
- By:
- Publication type:
- Article
6
Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists.
- Published in:
- BioDrugs, 2017, v. 31, n. 5, p. 447, doi. 10.1007/s40259-017-0244-3
- By:
- Publication type:
- Article
7
GP2013: A Rituximab Biosimilar.
- Published in:
- BioDrugs, 2017, v. 31, n. 5, p. 465, doi. 10.1007/s40259-017-0245-2
- By:
- Publication type:
- Article
8
Metabolic Enzymes in Sarcomagenesis: Progress Toward Biology and Therapy.
- Published in:
- BioDrugs, 2017, v. 31, n. 5, p. 379, doi. 10.1007/s40259-017-0237-2
- By:
- Publication type:
- Article